Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 6
1999 11
2000 10
2001 3
2002 11
2003 12
2004 17
2005 26
2006 45
2007 49
2008 60
2009 74
2010 64
2011 103
2012 108
2013 97
2014 104
2015 109
2016 132
2017 107
2018 93
2019 96
2020 100
2021 109
2022 85
2023 88
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

1,671 results

Results by year

Filters applied: . Clear all
Page 1
Artemether-lumefantrine: an option for malaria.
Stover KR, King ST, Robinson J. Stover KR, et al. Ann Pharmacother. 2012 Apr;46(4):567-77. doi: 10.1345/aph.1Q539. Epub 2012 Apr 10. Ann Pharmacother. 2012. PMID: 22496476 Review.
DATA SOURCES: English-language articles indexed in PubMed (1947-November 2011) were identified, using the search terms artemether-lumefantrine, artemether-lumefantrine AND malaria, Coartem, and Coartem AND malaria. ...The dual mechanisms of action of …
DATA SOURCES: English-language articles indexed in PubMed (1947-November 2011) were identified, using the search terms artemether- …
Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.
Omari AA, Gamble C, Garner P. Omari AA, et al. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD005965. doi: 10.1002/14651858.CD005965. Cochrane Database Syst Rev. 2006. PMID: 16625646 Free PMC article. Review.
BACKGROUND: The World Health Organization recommends artemether-lumefantrine, an expensive drug, as a treatment for uncomplicated malaria. ...We also contacted experts in malaria research and the pharmaceutical company that manufactures artemether-l …
BACKGROUND: The World Health Organization recommends artemether-lumefantrine, an expensive drug, as a treatment for unc …
Artemether-lumefantrine for treating uncomplicated falciparum malaria.
Omari AA, Preston C, Garner P. Omari AA, et al. Cochrane Database Syst Rev. 2002;(3):CD003125. doi: 10.1002/14651858.CD003125. Cochrane Database Syst Rev. 2002. PMID: 12137676 Updated. Review.
We contacted experts in malaria research and the pharmaceutical company that manufactures artemether-lumefantrine. SELECTION CRITERIA: Randomized and quasi-randomized trials comparing artemether-lumefantrine administered orally with standard treatment …
We contacted experts in malaria research and the pharmaceutical company that manufactures artemether-lumefantrine. SELECTION C …
Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.
Omari AA, Gamble C, Garner P. Omari AA, et al. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD005564. doi: 10.1002/14651858.CD005564. Cochrane Database Syst Rev. 2005. PMID: 16235412 Free PMC article. Review.
OBJECTIVES: To evaluate the six-dose regimen of artemether-lumefantrine for treating uncomplicated falciparum malaria. ...We also contacted experts in malaria research and the pharmaceutical company that manufactures artemether-lumefantrine. SELECTION …
OBJECTIVES: To evaluate the six-dose regimen of artemether-lumefantrine for treating uncomplicated falciparum malaria. ...We a …
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Ocan M, Nakalembe L, Otike C, Omali D, Buzibye A, Nsobya S. Ocan M, et al. Malar J. 2023 May 26;22(1):165. doi: 10.1186/s12936-023-04600-8. Malar J. 2023. PMID: 37237283 Free PMC article.
The most common batch of AL was LONART, 32.4% (24/74), with 33.8% (25/74) being 'Green leaf'. Overall prevalence of substandard quality artemether-lumefantrine was 18.9% (14/74; 95% CI: 11.4-29.7). Substandard quality AL was significantly associated with setting (p …
The most common batch of AL was LONART, 32.4% (24/74), with 33.8% (25/74) being 'Green leaf'. Overall prevalence of substandard quality a …
Quantitative determination of the antimalarials artemether and lumefantrine in biological samples: A review.
Resende LA, da Silva PHR, Fernandes C. Resende LA, et al. J Pharm Biomed Anal. 2019 Feb 20;165:304-314. doi: 10.1016/j.jpba.2018.12.021. Epub 2018 Dec 13. J Pharm Biomed Anal. 2019. PMID: 30579231 Review.
Due to the widespread resistance of Plasmodium falciparum to conventional drugs, the first line treatment recommended by World Health Organization for uncomplicated malaria is artemisinin-based combined therapy (ACT), which combines two drugs with different mechanisms of action. …
Due to the widespread resistance of Plasmodium falciparum to conventional drugs, the first line treatment recommended by World Health Organi …
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Nyangulu W, Mungwira RG, Divala TH, Nampota-Nkomba N, Nyirenda OM, Buchwald AG, Miller J, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa JE, van Oosterhout JJ, Parikh S, Laurens MB, Laufer MK; TSCQ Study Team. Nyangulu W, et al. Malar J. 2023 Jan 27;22(1):32. doi: 10.1186/s12936-023-04466-w. Malar J. 2023. PMID: 36707795 Free PMC article. Clinical Trial.
BACKGROUND: When people with human immunodeficiency virus (HIV) infection (PWH) develop malaria, they are at risk of poor anti-malarial treatment efficacy resulting from impairment in the immune response and/or drug-drug interactions that alter anti-malarial metabol …
BACKGROUND: When people with human immunodeficiency virus (HIV) infection (PWH) develop malaria, they are at risk of poor anti-malarial trea …
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
Sugiarto SR, Singh B, Page-Sharp M, Davis WA, Salman S, Hii KC, Davis TME. Sugiarto SR, et al. Br J Clin Pharmacol. 2022 Feb;88(2):691-701. doi: 10.1111/bcp.15001. Epub 2021 Aug 12. Br J Clin Pharmacol. 2022. PMID: 34296469 Free article.
AIMS: The aim of this study was to assess the pharmacokinetic properties of artemether, lumefantrine and their active metabolites in Plasmodium knowlesi malaria. ...Artemether-lumefantrine treatment was well tolerated and parasite clearance was prompt. …
AIMS: The aim of this study was to assess the pharmacokinetic properties of artemether, lumefantrine and their active metaboli …
The clinical efficacy of artemether/lumefantrine (Coartem).
Makanga M, Krudsood S. Makanga M, et al. Malar J. 2009 Oct 12;8 Suppl 1(Suppl 1):S5. doi: 10.1186/1475-2875-8-S1-S5. Malar J. 2009. PMID: 19818172 Free PMC article. Review.
Current World Health Organization (WHO) guidelines for the treatment of uncomplicated falciparum malaria recommend the use of artemisinin-based combination therapy (ACT). Artemether/lumefantrine is an ACT prequalified by the WHO for efficacy, safety and quali …
Current World Health Organization (WHO) guidelines for the treatment of uncomplicated falciparum malaria recommend the use of artemisinin-ba …
Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis.
Ayalew MB. Ayalew MB. Infect Dis Poverty. 2017 Nov 15;6(1):157. doi: 10.1186/s40249-017-0372-5. Infect Dis Poverty. 2017. PMID: 29137664 Free PMC article. Review.
The aim of this study was to synthesize the available evidence on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia. ...CONCLUSIONS: This review found that the cure rate for uncomplicated P. falciparu …
The aim of this study was to synthesize the available evidence on the efficacy of artemether-lumefantrine in the treatment of …
1,671 results